Simulation study demonstrates improved sensitivity for sub-10 mm tumors via AI-guided ultrasound and virtual reality, highlighting potential for accessible clinical decision support.
This research poster presents a low-cost, portable framework that combines AI-based ultrasound lesion detection with Virtual Reality (VR) volumetric visualization to support earlier tumor detection and clinical decision-making. The proposed pipeline integrates ultrasound acquisition, speckle denoising, CNN-based lesion detection and segmentation, AI-assisted segmentation, 3D volumetric reconstruction, and VR visualization. Simulation results indicate that AI-enhanced ultrasound can substantially improve sensitivity for early-stage, sub-10 mm lesions compared with conventional B-mode ultrasound, while the VR component provides an intuitive three-dimensional representation of tumor size and shape. The proposed approach is designed with accessibility and clinical practicality in mind, particularly for settings where advanced MRI/CT facilities may be limited. The work also identifies prospective validation using de-identified clinical ultrasound data and radiologist ground truth as an important next step.
No takes yet. Share an insight, caveat, or question.
Asif Hossain (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: